Cargando…
Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
Our previous study found that the level of CCN1 increases as osteogenic differentiation progresses in tonsil-derived mesenchymal stem cells (TMSCs). This study investigated how CCN1 is regulated through HDAC inhibition in TMSCs and their relationship with osteogenesis. Valproic acid (VPA) (1–5 mM),...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834451/ https://www.ncbi.nlm.nih.gov/pubmed/35159343 http://dx.doi.org/10.3390/cells11030534 |
_version_ | 1784649190084706304 |
---|---|
author | Yu, Yeonsil Oh, Se-Young Kim, Ha Yeong Choi, Ji-Young Jo, Sangmee Ahn Jo, Inho |
author_facet | Yu, Yeonsil Oh, Se-Young Kim, Ha Yeong Choi, Ji-Young Jo, Sangmee Ahn Jo, Inho |
author_sort | Yu, Yeonsil |
collection | PubMed |
description | Our previous study found that the level of CCN1 increases as osteogenic differentiation progresses in tonsil-derived mesenchymal stem cells (TMSCs). This study investigated how CCN1 is regulated through HDAC inhibition in TMSCs and their relationship with osteogenesis. Valproic acid (VPA) (1–5 mM), a well-known histone deacetylase (HDAC) inhibitor, strongly inhibited TMSC proliferation without altering MSC-specific surface markers, CD14, 34, 45, 73, 90 and 105. However, CD146 expression increased at 5 mM VPA. VPA increased osteogenic differentiation of TMSCs but decreased adipogenesis and chondrogenesis, as evidenced by the cell-specific staining of differentiation. The former was validated by the increased osteocalcin (OCN). The changes in CCN1 by VPA was biphasic; it increased until 48 h and decreased thereafter. Knockdown of CCN1 by using siRNA inhibited the osteogenic effect of VPA. VPA had no effect on CCN1 mRNA expression, but inhibition of protein synthesis by cycloheximide showed that VPA slowed down the CCN1 protein degradation. Moreover, overexpression of HDAC1 completely inhibited VPA-induced CCN1. Our results indicate that VPA inhibits the HDAC1, inducing CCN1 protein stability rather than gene expression, thereby promoting osteogenic differentiation of TMSCs. These findings present the noble implication of VPA as an inhibitor of HDAC1 to facilitate CCN1-induced osteogenic differentiation of MSCs. |
format | Online Article Text |
id | pubmed-8834451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88344512022-02-12 Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells Yu, Yeonsil Oh, Se-Young Kim, Ha Yeong Choi, Ji-Young Jo, Sangmee Ahn Jo, Inho Cells Article Our previous study found that the level of CCN1 increases as osteogenic differentiation progresses in tonsil-derived mesenchymal stem cells (TMSCs). This study investigated how CCN1 is regulated through HDAC inhibition in TMSCs and their relationship with osteogenesis. Valproic acid (VPA) (1–5 mM), a well-known histone deacetylase (HDAC) inhibitor, strongly inhibited TMSC proliferation without altering MSC-specific surface markers, CD14, 34, 45, 73, 90 and 105. However, CD146 expression increased at 5 mM VPA. VPA increased osteogenic differentiation of TMSCs but decreased adipogenesis and chondrogenesis, as evidenced by the cell-specific staining of differentiation. The former was validated by the increased osteocalcin (OCN). The changes in CCN1 by VPA was biphasic; it increased until 48 h and decreased thereafter. Knockdown of CCN1 by using siRNA inhibited the osteogenic effect of VPA. VPA had no effect on CCN1 mRNA expression, but inhibition of protein synthesis by cycloheximide showed that VPA slowed down the CCN1 protein degradation. Moreover, overexpression of HDAC1 completely inhibited VPA-induced CCN1. Our results indicate that VPA inhibits the HDAC1, inducing CCN1 protein stability rather than gene expression, thereby promoting osteogenic differentiation of TMSCs. These findings present the noble implication of VPA as an inhibitor of HDAC1 to facilitate CCN1-induced osteogenic differentiation of MSCs. MDPI 2022-02-03 /pmc/articles/PMC8834451/ /pubmed/35159343 http://dx.doi.org/10.3390/cells11030534 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Yeonsil Oh, Se-Young Kim, Ha Yeong Choi, Ji-Young Jo, Sangmee Ahn Jo, Inho Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells |
title | Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells |
title_full | Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells |
title_fullStr | Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells |
title_full_unstemmed | Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells |
title_short | Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells |
title_sort | valproic acid-induced ccn1 promotes osteogenic differentiation by increasing ccn1 protein stability through hdac1 inhibition in tonsil-derived mesenchymal stem cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834451/ https://www.ncbi.nlm.nih.gov/pubmed/35159343 http://dx.doi.org/10.3390/cells11030534 |
work_keys_str_mv | AT yuyeonsil valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells AT ohseyoung valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells AT kimhayeong valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells AT choijiyoung valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells AT josangmeeahn valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells AT joinho valproicacidinducedccn1promotesosteogenicdifferentiationbyincreasingccn1proteinstabilitythroughhdac1inhibitionintonsilderivedmesenchymalstemcells |